Stevens Capital Closes Out Position in Eli Lilly
According to a filing with the Securities and Exchange Commission dated Aug. 12, 2025, Stevens Capital Management LP completely exited its position in Eli Lilly and Company (NYSE:LLY), by selling all 12,036 shares in Q2 2025.
The estimated transaction value, based on the average price for the quarter ended June 30, 2025, was approximately $9.94 million.
The following are the fund's top holdings post-filing at the end of the second quarter:
Source Fool.com
